PubMed:16309808 / 184-367 JSONTXT

{"project":"LitCoin-sentences","denotations":[{"id":"T3","span":{"begin":0,"end":183},"obj":"Sentence"}],"text":"For example, the symptoms of RLS can be dramatically improved by levodopa and dopamine agonists, whereas central dopamine D2 receptor antagonists can induce or aggravate RLS symptoms."}

{"project":"LitCoin-entities","denotations":[{"id":"2572","span":{"begin":29,"end":32},"obj":"DiseaseOrPhenotypicFeature"},{"id":"2573","span":{"begin":65,"end":73},"obj":"ChemicalEntity"},{"id":"2574","span":{"begin":78,"end":86},"obj":"ChemicalEntity"},{"id":"2575","span":{"begin":113,"end":145},"obj":"ChemicalEntity"},{"id":"2576","span":{"begin":170,"end":173},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A6","pred":"db_id","subj":"2572","obj":"MESH:D012148"},{"id":"A7","pred":"db_id","subj":"2573","obj":"MESH:D007980"},{"id":"A8","pred":"db_id","subj":"2574","obj":"MESH:D004298"},{"id":"A9","pred":"db_id","subj":"2575","obj":"MESH:D065127"},{"id":"A10","pred":"db_id","subj":"2576","obj":"MESH:D012148"}],"namespaces":[{"prefix":"_base","uri":"https://w3id.org/biolink/vocab/"},{"prefix":"MESH","uri":"http://id.nlm.nih.gov/mesh/"},{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id="},{"prefix":"NCBIGene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"OMIM","uri":"https://www.omim.org/entry/"},{"prefix":"DBSNP","uri":"https://www.ncbi.nlm.nih.gov/snp/"}],"text":"For example, the symptoms of RLS can be dramatically improved by levodopa and dopamine agonists, whereas central dopamine D2 receptor antagonists can induce or aggravate RLS symptoms."}

{"project":"LitCoin-GeneOrGeneProduct-v0","denotations":[{"id":"T5","span":{"begin":113,"end":133},"obj":"GeneOrGeneProduct"},{"id":"T6","span":{"begin":134,"end":145},"obj":"GeneOrGeneProduct"},{"id":"T7","span":{"begin":150,"end":156},"obj":"GeneOrGeneProduct"}],"text":"For example, the symptoms of RLS can be dramatically improved by levodopa and dopamine agonists, whereas central dopamine D2 receptor antagonists can induce or aggravate RLS symptoms."}

{"project":"LitCoin-GeneOrGeneProduct-v2","denotations":[{"id":"T5","span":{"begin":113,"end":133},"obj":"GeneOrGeneProduct"}],"text":"For example, the symptoms of RLS can be dramatically improved by levodopa and dopamine agonists, whereas central dopamine D2 receptor antagonists can induce or aggravate RLS symptoms."}

{"project":"LitCoin-Disease-MeSH","denotations":[{"id":"T4","span":{"begin":29,"end":32},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T5","span":{"begin":170,"end":173},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A4","pred":"originalLabel","subj":"T4","obj":"D012148"},{"id":"A5","pred":"originalLabel","subj":"T5","obj":"D012148"}],"text":"For example, the symptoms of RLS can be dramatically improved by levodopa and dopamine agonists, whereas central dopamine D2 receptor antagonists can induce or aggravate RLS symptoms."}

{"project":"LitCoin-GeneOrGeneProduct-v3","denotations":[{"id":"T3","span":{"begin":113,"end":133},"obj":"GeneOrGeneProduct"}],"text":"For example, the symptoms of RLS can be dramatically improved by levodopa and dopamine agonists, whereas central dopamine D2 receptor antagonists can induce or aggravate RLS symptoms."}

{"project":"LitCoin_Mondo_095","denotations":[{"id":"T5","span":{"begin":29,"end":32},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T7","span":{"begin":33,"end":36},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T8","span":{"begin":146,"end":149},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T9","span":{"begin":170,"end":173},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A5","pred":"mondo_id","subj":"T5","obj":"0017413"},{"id":"A6","pred":"mondo_id","subj":"T5","obj":"0005391"},{"id":"A7","pred":"mondo_id","subj":"T7","obj":"0012833"},{"id":"A8","pred":"mondo_id","subj":"T8","obj":"0012833"},{"id":"A9","pred":"mondo_id","subj":"T9","obj":"0017413"},{"id":"A10","pred":"mondo_id","subj":"T9","obj":"0005391"}],"text":"For example, the symptoms of RLS can be dramatically improved by levodopa and dopamine agonists, whereas central dopamine D2 receptor antagonists can induce or aggravate RLS symptoms."}

{"project":"LitCoin-MeSH-Disease-2","denotations":[{"id":"T4","span":{"begin":29,"end":32},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T5","span":{"begin":170,"end":173},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A4","pred":"ID:","subj":"T4","obj":"D012148"},{"id":"A5","pred":"ID:","subj":"T5","obj":"D012148"}],"text":"For example, the symptoms of RLS can be dramatically improved by levodopa and dopamine agonists, whereas central dopamine D2 receptor antagonists can induce or aggravate RLS symptoms."}

{"project":"LitCoin-MONDO_bioort2019","denotations":[{"id":"T4","span":{"begin":29,"end":32},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T5","span":{"begin":170,"end":173},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A4","pred":"#label","subj":"T4","obj":"D012148"},{"id":"A5","pred":"#label","subj":"T5","obj":"D012148"}],"text":"For example, the symptoms of RLS can be dramatically improved by levodopa and dopamine agonists, whereas central dopamine D2 receptor antagonists can induce or aggravate RLS symptoms."}

{"project":"LitCoin-Chemical-MeSH-CHEBI","denotations":[{"id":"T6","span":{"begin":65,"end":73},"obj":"ChemicalEntity"},{"id":"T7","span":{"begin":78,"end":86},"obj":"ChemicalEntity"},{"id":"T10","span":{"begin":113,"end":145},"obj":"ChemicalEntity"}],"attributes":[{"id":"A6","pred":"ID:","subj":"T6","obj":"http://purl.obolibrary.org/obo/CHEBI_15765"},{"id":"A7","pred":"ID:","subj":"T7","obj":"D004298"},{"id":"A8","pred":"ID:","subj":"T7","obj":"http://purl.obolibrary.org/obo/CHEBI_59905"},{"id":"A9","pred":"ID:","subj":"T7","obj":"http://purl.obolibrary.org/obo/CHEBI_18243"},{"id":"A10","pred":"ID:","subj":"T10","obj":"ChemicalEntity"}],"text":"For example, the symptoms of RLS can be dramatically improved by levodopa and dopamine agonists, whereas central dopamine D2 receptor antagonists can induce or aggravate RLS symptoms."}

{"project":"LitCoin-training-merged","denotations":[{"id":"T10","span":{"begin":113,"end":145},"obj":"ChemicalEntity"},{"id":"T7","span":{"begin":78,"end":86},"obj":"ChemicalEntity"},{"id":"T6","span":{"begin":65,"end":73},"obj":"ChemicalEntity"},{"id":"T2413","span":{"begin":113,"end":133},"obj":"GeneOrGeneProduct"},{"id":"T36929","span":{"begin":170,"end":173},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T89707","span":{"begin":29,"end":32},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A10","pred":"ID:","subj":"T10","obj":"ChemicalEntity"},{"id":"A9","pred":"ID:","subj":"T7","obj":"http://purl.obolibrary.org/obo/CHEBI_18243"},{"id":"A8","pred":"ID:","subj":"T7","obj":"http://purl.obolibrary.org/obo/CHEBI_59905"},{"id":"A7","pred":"ID:","subj":"T7","obj":"D004298"},{"id":"A6","pred":"ID:","subj":"T6","obj":"http://purl.obolibrary.org/obo/CHEBI_15765"},{"id":"A77362","pred":"#label","subj":"T36929","obj":"D012148"},{"id":"A26731","pred":"#label","subj":"T89707","obj":"D012148"}],"text":"For example, the symptoms of RLS can be dramatically improved by levodopa and dopamine agonists, whereas central dopamine D2 receptor antagonists can induce or aggravate RLS symptoms."}